BALPHARMA2024-01-012024-03-31 BALPHARMA2024-01-012024-03-31 BALPHARMA2024-01-012024-03-31in-bse-fin:OneOperatingExpenses01Member BALPHARMA2024-01-012024-03-31in-bse-fin:FourOperatingExpenses01Member BALPHARMA2024-03-31 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 524824 BALPHARMA NOTLISTED Bal Pharma Limited Equity 2023-04-01 2024-03-31 2024-05-28 2024-04-30 INR Lakhs Yearly 16:30:00 17:45:00 2024-05-28 2024-05-28 true Cash Flow Indirect Declaration of unmodified opinion Single segment PHARMACEUTICLES 2024-01-01 2024-03-31 Audited Consolidated 946260000.00 24541000.00 970801000.00 519006000.00 47488000.00 -28835000.00 156365000.00 41395000.00 21551000.00 156317000.00 913287000.00 57514000.00 0.00 57514000.00 10213000.00 -8024000.00 2189000.00 0.00 55325000.00 0.00 0.00 0.00 0.00 55325000.00 3608000.00 58933000.00 54733000.00 591000.00 0.00 0.00 158043000.00 10 3.73 3.74 0.00 0.00 3.73 3.74 1. The above audited consolidated financial results of the company have been reviewed by the Audit Committee and approved by the Board of DIrectors at their repective meetings held on 28 May 2024. 2. The Consolidated financial results has been prepared in accordance with the COmpanies ( Indian Accounting Standards ) Rules, 2015 ( IND AS ), prescribed under section 133 of Companies Act, 2013, read with relevant rules issued thereunder and oother recognised accounting practices and policies to the extent applicable. The Audited consolidated financial results relate to Bal Pharma Limited., its subsidiaries ( together constitute the group ). The Joint Venture and associates and are preparely applying IND AS 110- Consolidated Financial Statements , and IND AS 28- Investments in Associates & Joint Ventures . 3. The Group has not received any intimation or information with regard to its vendors registration as a Micro, Small and Medium enterprises. Accordingly, the entire dues to vendors has been classified as payable to other than MSME. 4. The Company has a outstanding recoveribility of RS 869.89 Lakhs and Rs. 152.23 Lakhs from its subsidiaries Lifezen Healthcare Pivate Limited and Balance Clinics LLP. The said subsidiaries have incurred losses and have a negative networth. How ever the Management is confident that with infusion of additional funds, introduction of new brands and renewed marketing, internal restructuring, the companies can be revived and the amounts recovered. 5. The figures for the year ended 31 March 2023 & 31 March 2022 are balancing figure between Audited figures in respect of full FY and the unaudited published year to date figures up to the third Quarter of the relevant FY which were subject to Limited Review by the Statutory Auditor of the Company. 6. The Company Has only one reportable segment namely Pharmaceuticals . 7. The Company has filed application with NCLT for merger of Golden Drugs Pvt Ltd , a wholly owned subsdiary of the Company. 8. The Company has made the grant of 4,16,500 stock options during the Year 2021-22 under Bal Pharma Limited employee Stock exchange Scheme 2014 to its employees. These Stock Options will vest in line with the Scheme. 9. Previous Period figures have been regrouped/ rearranged wherever considered necessary to the period presentation. Single segment 2023-04-01 2024-03-31 Audited Consolidated 3392196000.00 28482000.00 3420678000.00 1815767000.00 112401000.00 -10649000.00 603771000.00 152578000.00 100711000.00 555626000.00 3330205000.00 90473000.00 0.00 90473000.00 32023000.00 -16007000.00 16016000.00 0.00 74457000.00 0.00 0.00 0.00 0.00 74457000.00 3608000.00 78065000.00 73922000.00 535000.00 0.00 0.00 158043000.00 10 0.00 4.94 4.96 0.00 0.00 4.94 4.96 Other Expenses 156317000.00 Other Expenses 555626000.00 -329000.00 616051000.00 4722000.00 0.00 38286000.00 113814000.00 0.00 0.00 0.00 0.00 0.00 1166000.00 26654000.00 27820000.00 24121000.00 28975000.00 853789000.00 878114000.00 67567000.00 996218000.00 41958000.00 90965000.00 13679000.00 10122000.00 1220509000.00 1167000.00 250311000.00 2350101000.00 0.00 0.00 3203890000.00 158044000.00 534899000.00 692943000.00 692614000.00 363824000.00 0.00 17923000.00 381747000.00 50860000.00 39610000.00 0.00 0.00 472217000.00 1032660000.00 783278000.00 93476000.00 1909414000.00 97982000.00 9487000.00 22176000.00 0.00 2039059000.00 0.00 0.00 2511276000.00 3203890000.00 -5478000.00 -826000.00 0.00 -10353000.00 152564000.00 -10357000.00 3515000.00 100711000.00 1930000.00 -11795000.00 0.00 3537000.00 101936000.00 -149541000.00 6609000.00 98000.00 10292000.00 -5951000.00 13258000.00 -20459000.00 3330000.00 -109800000.00 119000.00 -86114000.00 6886000.00 58263000.00 103613000.00 -15690000.00 12281000.00 351746000.00 442219000.00 -7269000.00 -163263000.00 2708600000.00 14871000.00 0.00 3291942000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 58263000.00 0.00 0.00 103613000.00 -15690000.00 0.00 12281000.00 0.00 -7269000.00 -163263000.00 0.00 0.00 0.00 0.00 0.00 0.00 345841000.00 3637783000.00 0.00 3637783000.00 0.00 3637783000.00